Analysts' Actions: CHK, JNJ, BIIB, CNO, UNH


Chase ( CCF) downgraded to hold at TheStreet Ratings.

Chesapeake Energy ( CHK) downgraded at Bernstein from Outperform to Market Perform, Bernstein Research said. $21 price target. Company lacks near-term catalysts.

Majesco Entertainment ( COOL) downgraded to hold at TheStreet Ratings.

E*Trade ( ETFC) upgraded at BGB from Sell to Hold, BGB Securities said. Valuation call, based on a $7.50 price target.

Fortinet ( FTNT) upgraded at UBS to Buy from Neutral, UBS said. $28 price target. Upside to street estimates on increasing market share.

Genon Energy ( GEN) upgraded at UBS to Neutral from Sell, UBS said. $1.50 price target. Shares fairly valued.

Hill-Rom ( HRC) upgraded at BofA/Merrill from Underperform to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $34 price target.

Johnson & Johnson ( JNJ) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. $74 price target.

McDonald's ( MCD) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. $92 price target. Company faces multiple growth headwinds.

Navistar ( NAV) upgraded at JP Morgan from Underweight to Neutral, JP Morgan said. Risk/reward is more balanced at current levels.

Petrologistics ( PDH) rated new Buy at UBS. $16.50 price target. Propylene price dip and stock weakness gives a good buying opportunity.

PetSmart ( PETM) rated new Overweight at Morgan Stanley. $75 price target. Company can deliver stable growth and gain market share.

Power Integrations ( POWI) downgraded at Sterne Agee from Buy to Neutral, Sterne Agee said. Company will likely face weaker customer demand. $43 price target.

UnitedHealth ( UNH) rated new Overweight at JP Morgan. $72 price target. Company remains a core holding, despite industry regulatory risks.

Woodward ( WWD) rated new Buy at Keybanc. $45 price target. Company is leveraged to late-cycle secular growth.


Biogen Idec ( BIIB) target raised at Oppenheimer to $145. Analyst day highlights pipeline strength. Outperform rating.

CNO Financial ( CNO) added to Conviction Buy List at Goldman. Company can grow faster than its life insurance peers. Buy rating and $9 price target.

Forest Laboratories ( FRX) estimates cut at Morgan Stanley through 2014, Morgan Stanley said. Company lowered its guidance. $35 price target.

Great Plains Energy ( GXP) added to Top Picks Live! at Citigroup. $23 price target. Valuation gap should narrow as rates come closer to fruition and regulatory concerns diminish.

Hershey ( HSY) added to Conviction Buy List at Goldman. Company can deliver above-average sales and earnings growth. $76 price target.

JPMorgan Chase ( JPM) target lowered at Oppenheimer to $56. Contraction of market multiple. Outperform rating.

Mastercard ( MA) numbers lowered at Jefferies. Shares of MA now seen reaching $507, Jefferies said. Estimates also lowered on FX and macro risks. Buy rating.

Altria ( MO) target raised at Morgan Stanley to $30, according to Morgan Stanley. There's room for industry price increases in the U.S.

Scotts Miracle-Gro ( SMG) numbers cut at BofA/Merrill. Shares of SMG now seen reaching $39, according to Bank of America/Merrill Lynch. Estimates also reduced, given the company's new guidance. Underperform rating.

AT&T ( T) target raised at Jefferies to $36, Jefferies said. Divestiture of Advertising Solutions should help value gap close. Hold rating.

>To submit a news tip, email:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.